Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Submitted by
admin
on February 26, 2015 - 10:26am
Source:
Fierce Biotech
News Tags:
Amgen
AMG416
Sensipar
secondary hyperparathyroidism
Headline:
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Do Not Allow Advertisers to Use My Personal information
